Photo by National Institute of Allergy and Infectious Diseases on Unsplash
In A Nutshell
- Scientists turned patchouli essential oil into a skin cream that provided 100% protection against Aedes aegypti mosquitoes for three hours in a controlled lab test.
- Two compounds in patchouli oil, alpha-guaiene and beta-elemene, bound to mosquito smell-sensing proteins with affinities similar to DEET in computer modeling, offering a possible explanation for why it works.
- Early computational safety screening raised some warning flags around skin irritation and liver stress for certain compounds, and the authors say follow-up lab and clinical testing is needed before any firm safety conclusions can be drawn.
- A cream formulation remained stable over 90 days across multiple storage conditions, a practical hurdle many natural repellents fail to clear.
Patchouli, the earthy, musky scent most people associate with incense or vintage health food stores, may be doing something far more useful than setting a mood. Scientists have turned its essential oil into a skin cream that kept disease-carrying mosquitoes from landing or biting for a full three hours in a laboratory test.
Researchers developed and tested a topical cream made from patchouli essential oil against Aedes aegypti, the mosquito responsible for spreading dengue fever, Zika, chikungunya, and yellow fever. At 200 parts per million, the cream provided 100% protection for 180 minutes, based on the study’s landing and biting observations, a meaningful result for anyone living in or traveling to regions where these diseases are a daily threat.
Dengue alone infects hundreds of millions of people each year. DEET, the synthetic chemical found in most commercial repellents, works well but has drawn scrutiny for safety concerns and environmental persistence. That’s pushed scientists to look harder at plant-based options that might work just as well while being gentler on people and the planet.
What’s in the Patchouli Cream and Why It Matters
Patchouli essential oil is a chemical cocktail. When researchers analyzed it, they found 16 different compounds, most of them plant-derived chemicals called terpenes. Most abundant was patchouli alcohol, making up roughly 40% of the oil.
Scientists blended the oil into a standard lotion base and tested it at two different concentrations. At the lower dose, protection was weak. At 200 parts per million, the cream held strong for the entire three-hour testing window, showing lab performance that makes it worth comparing with established repellents. That tracks with earlier work cited in the study, in which patchouli alcohol tested as an isolated compound delivered full protection for up to 280 minutes, suggesting the key ingredient was already pulling its weight well before anyone put it in a cream.
How the Aedes aegypti Repellency Test Worked
Following a protocol recommended by the World Health Organization, researchers placed 50 adult female Aedes aegypti, all between five and seven days old, inside enclosed cages roughly the size of a large storage bin and deprived them of food for 24 hours to ensure they were motivated to feed. Healthy volunteers exposed their forearms inside the cages after applying one milliliter of the test cream, with observations recorded every 30 minutes over three hours. A DEET-based commercial repellent served as the benchmark, while a neutral solution served as the negative control. Statistical analysis found that the type of treatment was the main driver of repellency, though time and the interaction between time and treatment also mattered.
Computer Modeling Points to How It Works
Mosquitoes find their human targets largely through smell. Specialized proteins in their antennae act like molecular locks, and when a scent molecule fits into one, it triggers a chain reaction that steers the mosquito toward its next meal. Repellents work, at least in part, by jamming those locks.
Computer modeling suggested that two patchouli oil compounds, alpha-guaiene and beta-elemene, may bind to mosquito odor-related proteins with affinities similar to DEET, offering a possible explanation for the repellent effect observed in the lab. Alpha-guaiene’s binding strength differed from DEET’s by just a fraction of a measurement unit, which the authors described as strongly reinforcing its potential.
Early computer-based safety screening looked generally compatible with topical use at this low concentration, but it also raised warning flags that need lab and clinical follow-up. A handful of compounds triggered high-risk alerts related to skin irritation, and others raised concerns related to liver stress under certain exposure conditions. None showed signs of being able to cause genetic mutations. Published in ACS Omega, the study called for follow-up toxicological and clinical work before drawing any firm safety conclusions.
A repellent that separates, changes, or loses stability before it reaches a mosquito would not be much use. So the research team monitored the cream over 90 days under several storage conditions: room temperature, refrigeration, heat, and direct light exposure. Throughout that period, it showed no separation, no cloudiness, no change in color or smell, and maintained a pH range compatible with human skin.
Why This Patchouli Repellent Research Is Worth Watching
Plenty of “natural” repellents smell pleasant but wear off too quickly or simply don’t work. This study pushes back against that assumption, at least for patchouli oil. Laboratory repellency data, computer modeling pointing to a plausible biological mechanism, and a stable cream formulation make this one of the more complete early-stage evaluations of a botanical repellent published in recent years.
With mosquito-borne diseases expanding their geographic reach as global temperatures rise, a shelf-stable, plant-based cream with promising early lab results is worth paying close attention to.
Disclaimer: This study was conducted under controlled laboratory conditions and has not been evaluated for real-world use, outdoor effectiveness, or long-term safety in humans. Findings should not be interpreted as medical advice or as an endorsement of patchouli-based products as a substitute for established mosquito repellents.
Paper Notes
Limitations
Repellency testing was conducted under controlled laboratory conditions using an arm-in-cage method, which may not fully replicate real-world scenarios such as outdoor environments, variable temperatures, sweat, or clothing. Safety assessments relied on computer-based predictions rather than clinical or laboratory toxicology testing on animals or humans. The authors explicitly noted that hepatotoxicity, carcinogenicity, and skin irritation alerts appeared for some compounds in computational models, and called for further targeted toxicological and clinical studies to confirm long-term safety before broader conclusions can be drawn. Results may vary at other doses or with different formulation compositions.
Funding and Disclosures
Publication of this research was funded by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil. Additional acknowledgments were made to the Amapá Foundation for Research Support (FAPEAP), the Research Program of SUS (PPSUS), the National Council of Scientific and Technological Development (CNPq), and the Pro-rector of Research and Postgraduation (PROPESPG) of the Federal University of Amapá. The authors declared no competing financial interest.
Publication Details
Authors: Lizandra Lima Santos, Lethicia Barreto Brandão, Alex Bruno Lobato Rodrigues, Rosany Lopes Martins, Anderson Luiz Pena da Costa, Cleidjane Gomes Faustino, Fernando Antônio de Medeiros, and Sheylla Susan Moreira da Silva de Almeida, all affiliated with the Federal University of Amapá, Macapá, Amapá, Brazil. | Journal: ACS Omega | Paper Title: “Development and In Silico/In Vivo Evaluation of a Pogostemon cablin Essential Oil Cream as a Repellent against Aedes aegypti” | Published: 2026, Volume 11, Pages 21274–21286 | DOI: https://doi.org/10.1021/acsomega.6c00802
